Trademark Overview
On Tuesday, June 4, 2024, a trademark application was filed for SELFTACS with the United States Patent and Trademark Office. The USPTO has given the SELFTACS trademark a serial number of 98583034. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 4, 2024. This trademark is owned by Kesmalea Therapeutics Limited. The SELFTACS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; software; software for use in scientific and/or pharmaceutical research and development; software for scientific modelling; software for pharmaceutical modelling; software for research and development in the field of oncology, immunology and central nervous system disease; software for the managing, analysis, and visualisation of biological data; devices for analysing protein sequence used as laboratory apparatus
Pharmaceutical preparations; pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for the treatment of central nervous system diseases; biological preparations for medical use; immunotherapeutic drugs; reagents for medical use; diagnostic preparations; diagnostic reagents for medical use; protein synthesis inhibitors
Proteins for use in science; regulatory proteins for scientific and medical use; chemical reagents for use in biotechnology, other than for medical or veterinary use
Medical services; medical analysis services; oral medical care services; medical diagnostic services; diagnostic and prognostic medical services; advisory services relating to medical services; medical screening and assaying; medical services in the field of oncology and immunotherapy; pharmacy advice; medical and health services relating to antibodies, immuno-oncology, inflammation, haematology, central nervous system and infectious disease; medical screening and assaying
Surgical, medical, dental and veterinary apparatus and instruments; medical devices; apparatus for drug administration; diagnostic apparatus for the detection of abnormal prion protein
Scientific, medical and technological services and research and design relating thereto; research relating to molecular sciences; analysis in the field of molecular biology; drug discovery services; clinical research; medical research; biological research; research relating to pharmaceuticals; pharmaceutical research and development; development of pharmaceutical preparations and medicines; platform as a service [PaaS]; platform as a service [PaaS] featuring medical analysis software; software as a service [Saas]; software as a service [Saas] featuring medical analysis software; provision of non-downloadable software for the management, visualisation and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; biotechnology research; biotechnology testing; research and development in the pharmaceutical and biotechnology fields; scientific screening and assaying; chemical analysis; chemical research; medical research ...
